Xiang Zhiquan, Li Yan, Gao Guangping, Wilson James M, Ertl Hildegund C J
Wistar Institute, Philadelphia, PA 19104, USA.
J Immunol. 2003 Oct 15;171(8):4287-93. doi: 10.4049/jimmunol.171.8.4287.
E1-deleted adenoviral vectors of the human serotype 5 (AdHu5) and the chimpanzee serotype 68 (AdC68) expressing the rabies virus glycoprotein (rab.gp) were tested for induction of transgene product-specific Abs upon intranasal or oral immunization of newborn mice. Both vectors induced Abs to rabies virus that could be detected in serum and from mucosal secretions. Serum rabies virus neutralizing Ab titers sufficed to protect neonatally vaccinated mice against a subsequent challenge with rabies virus. The efficacy of the AdHu5rab.gp vector given orally to newborn mice born to AdHu5 virus-immune dams was not impaired by maternally transferred Abs to the vaccine carrier.
对表达狂犬病病毒糖蛋白(rab.gp)的人5型血清型(AdHu5)和黑猩猩68型血清型(AdC68)的E1缺失腺病毒载体,在新生小鼠经鼻内或口服免疫后,检测其转基因产物特异性抗体的诱导情况。两种载体均诱导产生了可在血清和黏膜分泌物中检测到的针对狂犬病病毒的抗体。血清狂犬病病毒中和抗体滴度足以保护新生期接种疫苗的小鼠免受随后狂犬病病毒的攻击。给AdHu5病毒免疫的母鼠所生的新生小鼠口服AdHu5rab.gp载体的效果,并未因母源转移至疫苗载体的抗体而受损。